Highly ranked in the U.S. for Cancer
Recently Added |view more
Cedars-Sinai Cancer’s Blood and Marrow Transplant Patients Experience Superior Outcomes
Allogeneic transplants use blood stem cells from donors’ bone marrow to treat patients with blood and bone marrow diseases. The Cedars-Sinai team performs more than 40 such transplants each year.
A Clinic for Ovarian Cancer ‘Previvors’
Cedars-Sinai Cancer’s One-Stop Option Helps BRCA1- and BRCA2-Positive Patients Manage Fertility, Risk
Faculty Publications March 28-April 4
This week’s edition of Faculty Publications includes Cedars-Sinai studies that were published March 28-April 4.
Pediatric Cancer Expert Explains New Options for Children With Sarcomas
Q&A With Cedars-Sinai Guerin Children’s Pediatric Hematologist-Oncologist Leo Mascarenhas, MD, MS
Cedars-Sinai Cancer Releases 2024 Annual Report
The 2024 Cedars-Sinai Cancer Annual Report is now accessible. By harnessing the collective expertise of top cancer researchers and leveraging leading-edge Al technology, Cedars-Sinai Cancer is transforming cancer research and patient care ...
Building a Diverse Pool of Leaders in Cancer Care and Research
Cedars-Sinai Cancer provides an equitable and inclusive future in cancer research and clinical care for a diverse population by targeting every level of learner—from high school students through senior faculty.
Crafting Technologies to Reshape the Future of Medicine
Multidisciplinary teams of Cedars-Sinai researchers advance emerging technologies, such as AI and proteomics, to establish new norms in oncology practice.
Changing Medical Practice Through Translational Research Successes
Converting data and science into medical progress requires a strategic emphasis on work that matters to patients, either through imminent application to clinical practice or potentially transformative basic discoveries.
Leading From the Lab: Basic Science Advancements of Clinical Consequence
The breadth and richness of basic science research underway at Cedars-Sinai Cancer has wide-ranging implications that alter the approach to cancer care—and future research—here and around the world.
Newsroom: Cancer
Getting Under the Skin at May 11 Symposium on Melanoma
Wednesday, May 1, 2024 9:30 AM
Monday, April 29, 2024 12:28 PM
Making Resistant Tumors Vulnerable to Treatment
Friday, April 19, 2024 11:15 AM